Antidiabetics Market Overview:

Anti-diabetics medicines are also known as oral hypoglycemic/antihyperglycemic therapies and are used to treat diabetes mellitus. With the rising frequency of diabetes mellitus, the anti-diabetics industry has exploded in recent years.. Global diabetes patient is expected to rise from 366 million in 2011 to 552 million by 2030, according to the International Diabetes Federation. The market is likely to benefit in the future as a result of the huge increase of diabetic patients. Other factors such as the ageing population, rising obesity cases, and the development of new products with diabetes affecting middle age groups and children across all income levels worldwide are projected to help the market throughout the forecast period. Furthermore, the increased approval of antidiabetic medications, as well as a robust pool of antidiabetic drugs, are likely to provide considerable market expansion potential. SCO-094, Tirzepatide, Volagidemab, CT-388, GX G6, ORMD-0801, and more antidiabetic drugs are in the pipeline. Also, the growing number of FDA drug approvals is expected to provide considerable prospects for the players. The number of treatment options for T2DM is growing, with the FDA having authorised roughly 60 medications. A total of about 100 new anti-diabetic drugs are currently being tested in clinical studies. There are also new medication combinations comprising metformin, SGLT2 inhibitors, and dipeptidyl peptidase-4, in addition to the traditional treatments of insulin therapy and metformin (DPP4). Type 2 diabetes is becoming more common as people become older, as is the risk of vascular disease, coronary heart disease, and stroke. As a result, the market is likely to profit in the forecast period as a result of the need to control comorbidities .

FutureWise Market Research has instantiated a report that provides an intricate analysis of Antidiabetics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Antidiabetics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Antidiabetics Market:
• AstraZeneca
• Bayer Corporation
• Boehringer Ingelheim
• Bristol-Myers Squibb.
• Eli Lilly.
• Halozyme Therapeutics
• Johnson & Johnson
• Merck & Co. Inc.
• Novartis AG
• Novo Nordisk
• Oramed Pharmaceuticals Inc.
• Pfizer
• Sanofi
• Takeda Pharmaceutical
(Note: The list of the major players will be updated with the latest market scenario and trends)

Antidiabetics Market Segmentation:
By Product
• Insulin-based Antidiabetics
 o Rapid-Acting Analog
 o Long-Acting Analog
 o Premixed Insulin
 o Short-Acting Analog
 o Intermediate-Acting Insulin
• Antidiabetics Drug Class
 o Alpha-Glucosidases Inhibitors
 o Biguanides
 o Sulphonylureas
 o GLP-1 (Glucagon-like peptide) Agonists
 o DPP-IV (Dipeptidyl Peptidase) Inhibitors
 o Meglitinides
 o SGLT-II (Sodium-Glucose Transport Proteins) Inhibitors
 o Thiazolidinedione
By Patient Population
• Pediatrics
• Adults
• Geriatrics
By Route of Administration
• Insulin Syringes/ Insulin Pens
• Insulin Pumps
• Intravenous Infusion
• Oral
• Other Routes
By Region
• North America
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Antidiabetics Market By Product, By Patient Population, By Route of Administration and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics